Atlas Trials

Evaluation of the Efficacy and Tolerance of Low Doses of Ethosuximide in the Treatment of Peripheral Neuropathic Pain

Clinical trial NCT04431778 · UNKNOWN

Trial details

NCT number
NCT04431778
Sponsor
University Hospital, Clermont-Ferrand
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Peripheral Neuropathic Pain
Start date
2020-11-01
Primary completion
2023-11-30
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.